The low expression of PDHA1 protein is associated with poor clinical outcomes in HCC patients [27], and the serine site of PDHA1, an important regulatory site in PDHC, has the most mutations in its subunits. This evidence concerns the gene PDHA1 and hepatocellular carcinoma.